Lilly’s preventative migraine treatment receives US FDA green light
Eli Lilly’s migraine treatment was approved by the US FDA, closely following a positive CHMP opinion, and will potentially be made available without cost for the first year.
Archives for October 2, 2018
Novo Nordisk sets up stem cell manufacturing in California, US
Novo Nordisk will take over the lease of a manufacturing facility in Fremont, California, where the company will make stem cell-based therapies with optionally licensed technology.